Seminars in Nephrology
Volume 28, Issue 5 , Pages 481-487 , September 2008

Acute Kidney Injury in Pediatric Stem Cell Transplant Recipients

  • Joseph DiCarlo, MD

      Affiliations

    • Keck School of Medicine, University of Southern California, Los Angeles, CA
    • Corresponding Author InformationAddress reprint requests to Joseph DiCarlo, MD, Anesthesiology Critical Care Medicine, Childrens Hospital Los Angeles, M/S #12, Los Angeles, CA 90027
    • ,
  • Steven R. Alexander, MD

      Affiliations

    • Pediatric Nephrology, Stanford University School of Medicine, Lucile Packard Children's Hospital at Stanford, Stanford, CA

References 

  1. Symons JM, Picca S. Acute kidney injury and dialysis in children: illustrative cases. Sem Neph. 2008;28:431–435
  2. Clark JG, Madtes DK, Martin TR, Hackman RC, Farrand AL, Crawford SW. Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med. 1999;27:1800–1806
  3. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM, et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation. 2000;70:272–279
  4. Clark JG, Mandac JB, Dixon AE, Martin PJ, Hackman RC, Madtes DK. Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells. Transplantation. 2000;70:39–43
  5. Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J, et al. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood. 1998;92:2571–2580
  6. Takatsuka H, Wakae T, Mori A, Okada M, Okamoto T, Kakishita E. Effects of total body irradiation on the vascular endothelium. Clin Transplant. 2002;16:374–377
  7. Chasty RC, Lamb WR, Gallati H, Roberts TE, Brenchley PE, Yin JA. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1993;12:331–336
  8. Schots R, Van Riet I, Othman TB, Trullemans F, De Waele M, Van Camp B, et al. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;30:441–446
  9. Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant. 1998;22:79–85
  10. McCubbin MM, Trigg ME, Hendricker CM, Wagener JS. Bronchoscopy with bronchoalveolar lavage in the evaluation of pulmonary complications of bone marrow transplantation in children. Pediatr Pulmonol. 1992;12:43–47
  11. Eikenberry M, Bartakova H, Defor T, Haddad IY, Ramsay NK, Blazar BR, et al. Natural history of pulmonary complications in children after bone marrow transplantation. Biol Blood Marrow Transplant. 2005;11:56–64
  12. Keenan HT, Bratton SL, Martin LD, Crawford SW, Weiss NS. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit Care Med. 2000;28:830–835
  13. Jacobe SJ, Hassan A, Veys P, Mok Q. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Crit Care Med. 2003;31:1299–1305
  14. Bojko T, Notterman DA, Greenwald BM, De Bruin WJ, Magid MS, Godwin T. Acute hypoxemic respiratory failure in children following bone marrow transplantation: an outcome and pathologic study. Crit Care Med. 1995;23:755–759
  15. Rossi R, Shemie SD, Calderwood S. Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation. Crit Care Med. 1999;27:1181–1186
  16. Litalien CDM, DiCarlo J. Oxygenation index and alveolar-arterial oxygen gradient predict mortality in pediatric bone marrow transplantation. Pediatr Res. 1998;43:39A
  17. Rajantie J. Hyperferritinaemia in children undergoing bone marrow transplantation. Bone Marrow Transplant. 1989;4(Suppl 3):92
  18. Or R, Matzner Y, Konijn AM. Serum ferritin in patients undergoing bone marrow transplantation. Cancer. 1987;60:1127–1131
  19. Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004;19:91–95
  20. Reising CA, Chendrasekhar A, Wall PL, Paradise NF, Timberlake GA, Moorman DW. Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS). J Surg Res. 1999;82:56–60
  21. DiCarlo JV, Alexander SR, Agarwal R, Schiffman JD. Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol. 2003;25:801–805
  22. Di Carlo JV, Alexander SR. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs. 2005;28:777–786
  23. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, et al. Continuous renal replacement therapy (CRRT) after stem cell transplantation (A report from the prospective pediatric CRRT Registry Group). Pediatr Nephrol. 2008;23:625–630
  24. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356:26–30

PII: S0270-9295(08)00116-2

doi: 10.1016/j.semnephrol.2008.05.008

Seminars in Nephrology
Volume 28, Issue 5 , Pages 481-487 , September 2008

Article Tools